The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 309-314

  Vairaktaris, Eleftherios ^a   Yapijakis, Christos ^a   Serefoglou, Zoe ^a   Derka, Spyridoula ^a   Vassiliou, Stavros ^a   Nkenke, Emeka ^b   Vylliotis, Antonis ^a   Spyridonidou, Sofia ^a   Neukam, Friedrich W ^b   Schlegel, Karl A ^b   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Inflammation; Interleukin 10; Oral cancer; Thrombophilia

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 40549094643     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McDowell JD: An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am 39: 277-294, 2006.
2. Tsai MH, Chen WC, Chen HY and Tsai FJ: Urokinase gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 18: 276-279, 2004.
3. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S and Neukam FW: Methylene-tetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006.
4. Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukman FW: Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892, 2006.
5. Vairaktaris E, Yiannopoulos A, Vylliotis A, Yapijakis C, Derka S, Vassiliou S, Nkenke E, Serefoglou Z, Ragos V, Papageorgiou G, Vorris E, Critseli E, Avgoustidis D, Neukam F and Patsouris E: Strong association of interleukin-6 -174G>C promoter polymorphism with increased risk of oral cancer. Int J Biol Markers 21: 246-250, 2006.
6. Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, Vylliotis A, Wiltfang J, Avgoustidis D, Critselis E, Patsouris E and Neukam FW: The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33: 504-507, 2006.
7. Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Critselis E, Avgoustidis D, Neukam FW and Patsouris E: Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep 17(4): 963-968, 2007.
8. Vairaktaris E, Yannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Critselis E, Avgoustidis D, Yapijakis C, Neukam FW and Patsouris E: Strong association of interleukin-4 (590C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(6): 796-802, 2007.
9. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, Neukam FW and Patsouris E: Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 46: 1097-1102, 2007.
10. Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, Gentilini O and Braga M: Increased interleukin-10 serum levels in patients with solid tumors. Cancer Lett 104: 1-5, 1996.
11. Karcher J, Reisser C, Daniel V and Herold-Mende C: Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels. Otolaryngology (HNO) 47: 879-884, 1999.
12. Fujieda S, Sunaga H, Tsuzuki H, Fank GK and Saito H: IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Letters 136: 1-9, 1999.
13. Cardillo MR, Sale P and Di Silverio F: Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res 20: 4579-4583, 2000.
14. Hatanaka H, Abe Y, Naruke M, Tokunaga T, Oshika Y, Kawakami T, Osada H, Nagata J, Kamochi J, Tsuchida T, Kijima H, Yamazaki H, Inoue H, Ueyama Y and Nakamura M: Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. Clin Cancer Res 7: 1287-1292, 2001.
15. de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM and Huizinga TW: Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol 63: 281-285, 2002.
16. Fernandez RP and Kaski JC: Interleukin-10 and Coronary Disease. Rev Esp Cardiol 55: 738-750, 2002.
17. Nagata J, Kijima H, Hatanaka H, Tokunaga T, Takagi A, Mine T, Yamazaki H, Nakamura M and Ueyama Y: Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med 10: 169-172, 2002.
18. de Vries JE: Immunosuppresive and anti-inflammatory properties of interleukin-10. Ann Med 27: 537-541, 1995.
19. Moore KW, de Waal Malefyt R, Coffman RL and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765, 2001.
20. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ and Hansen JA: Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplanation. N Engl J Med 349: 2201-2210, 2003.
21. Yilmaz V, Yentur SP and Saruhan-Direskeneli G: IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 30: 188-194, 2005.
22. Seifart C, Plagens A, Dempfle A, Clostermann U, Vogelmeier C, von Wichert P and Seifart U: TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21: 157-165, 2005.
23. Howell WM, Turner SJ, Bateman AC and Theaker JM: IL-10 promoter polymorphisms influence tumor development in cutaneous malignant melanoma. Genes Immun 2: 25-31, 2001.
24. McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A and Southgate C: Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Research 62: 3369-3372, 2002.
25. Savage SA, Abnet CC, Haque K, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR and Chanock SJ: Polymorphisms in interleukin-2,-6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk Chinese population. Cancer Epidemiol Biomark Prev 13: 1547-1549, 2004.
26. Guo W, Wang N, Wang YM, Li Y, Wen DG, Chen ZF, He YT and Zhang JH: Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of North China. World J Gastroenterol 11: 858-862, 2005.
27. Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, Leheny WA and Middleton D: Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 63: 1055-1061, 2002.
28. Voorzanger N, Touitou R, Garcia E, Delecluse HJ, Rousset F, Joab I, Favrot MC and Blay JY: Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and acts as cooperative growth factors. Cancer Res 56: 5499-5505, 1996.
29. Jin X, Kuang G, Wei LZ, Wang R, Guo W, Wang N, Fang SM, Wen DG, Chen ZF and Zhang JH: No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol 11: 2385-2389, 2005.
30. Cao ZG and Li CZ: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42: 32-38, 2006.